Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients Trial N/A Terminated June 1, 2023
Parkinson's Disease: Risk Assessment of Persistent Delirium and Its Management Trial N/A Unknown May 31, 2023
A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD Trial Phase 4 Completed May 31, 2023
Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD Trial Early Phase 1 Unknown May 30, 2023
Neuromodulation of Sleep Architecture by STN-DBS in Parkinsonian Patients Trial N/A Unknown May 29, 2023
A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease Trial Phase 2 Completed May 24, 2023
The Effect of Cognitive Functions on Upper Extremity Functionality in Parkinson's Patients Trial N/A Completed May 23, 2023
Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease Trial Phase 3 Completed May 23, 2023
Study of the Fecal Microbiome in Patients With Parkinson's Disease Trial Phase 1 Completed May 23, 2023
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) Trial Phase 2 Terminated May 23, 2023
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction Trial N/A Completed May 22, 2023
Effect of Safinamide on Parkinson's Disease Related Chronic Pain Trial Phase 4 Completed May 21, 2023
Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways Trial N/A Completed May 18, 2023
Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's Disease Trial N/A Unknown May 18, 2023